Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents-Reference-Cited by-同舟云学术

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents

Published:2016-01 Issue:1 Volume:14 Page:58-64
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Axelrad Jordan^ORCID,Bernheim Oren,Colombel Jean-Frederic,Malerba Stefano,Ananthakrishnan Ashwin,Yajnik Vijay,Hoffman Gila,Agrawal Manasi,Lukin Dana,Desai Amit,McEachern Elisa,Bosworth Brian,Scherl Ellen,Reyes Andre,Zaidi Hina,Mudireddy Prashant,DiCaprio David,Sultan Keith,Korelitz Burton,Wang Erwin,Williams Renee,Chen LeaAnn,Katz Seymour,Itzkowitz Steven

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Infliximab, azathioprine, or combination therapy for crohn's disease;Colombel;N Engl J Med,2010

2. Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: the UC success trial;Panccione;Gastroenterology,2011

3. The management of immunosuppression in patients with inflammatory bowel disease and cancer;Bernheim;Gut,2013

4. Cancer despite immunosurveillance: immunoselection and immunosubversion;Zitvogel;Nat Rev Immunol,2006

5. Immune escape by epstein-barr virus associated malignancies;Munz;Semin Cancer Biol,2008

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

3. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary;Clinical Gastroenterology and Hepatology;2024-07

4. Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry;Clinical Gastroenterology and Hepatology;2024-05

5. Progress in understanding of relationship between use of biological agents and risk of malignant tumors in patients with inflammatory bowel disease;World Chinese Journal of Digestology;2024-03-28